References - Therapeutic Strategies in Cancer Biology and Pathology - page 216

Hodgkinson, V.C., Agarwala, V., ElFadl, D., Fox, J.N., McManus, P.L., Mahapatra, T.K.,
et al., 2012. Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI
TOF/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant
chemotherapy in ER-positive breast cancer. J. Proteomics 75, 2745-2752.
Hoek, M., Myers, M.P., Stillman, B., 2011. An analysis of CAF-1-interacting proteins reveals
dynamic and direct interactions with the KU complex and 14-3-3 proteins. J. Biol. Chem.
286, 10876-10887.
Hoekstra, M., van der Sluis, R.J., Li, Z., Oosterveer, M.H., Groen, A.K., Van Berkel, T.J.C.,
2012. FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL/6 mice.
Mol. Cell. Endocrinol. 362, 69-75.
Holeiter, G., Heering, J., Erlmann, P., Schmid, S., Jaehne, R., Olayioye, M.A., 2008. Deleted
in liver cancer 1 controls cell migration through a Dial-dependent signaling pathway.
Cancer Res. 68, 8743-8751.
Holleman, A., Chung, I., Olsen, R.R., Kwak, B., Mizokami, A., Saijo, N., et al., 2011.
miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.
Oncogene 30, 4386-4398.
Holm, R., Ali, T., Svendsrud, D.H., Nesland, J.M., Kristensen, G.B., Lyng, H., 2009.
Expression of 14-3-3 sigma in cervical squamous cell carcinomas: relationship with clin-
ical outcome. Oncol. Rep. 22, 11-15.
Homma, Y., Emori, Y., 1995. A dual functional signal mediator showing RhoGAP and phos-
pholipase C-δ stimulating activities. EMBO J. 14, 286-291.
Hong, H.Y., Jeon, W.K., Bae, E.J., Kim, S.T., Lee, H.J., Kim, S.J., et al., 2010. 14-3-3 sigma
and 14-3-3 zeta plays an opposite role in cell growth inhibition mediated by transforming
growth factor-beta 1. Mol. Cells 29, 305-309.
Hooks, S.B., Callihan, P., Altman, M.K., Hurst, J.H., Ali, M.W., Murph, M.M., 2010.
Regulators of G-protein signaling RGS10 and RGS17 regulate chemoresistance in ovar-
ian cancer cells. Mol. Cancer 9, 289.
Horiuchi, A., Iinuma, H., Akahane, T., Shimada, R., Watanabe, T., 2012. Prognostic signifi-
cance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of
colorectal cancer patients. Oncol. Rep. 27, 1384-1392.
Hsieh, H.L., Schafer, B.W., Sasaki, N., Heizmann, C.W., 2003. Expression analysis of S100
proteins and RAGE in human tumors using tissue microarrays. Biochem. Biophys. Res.
Commun. 307, 375-381.
Hu, X.T., Zhang, F.B., Fan, Y.C., Shu, X.S., Wong, A.H., Zhou, W., et al., 2009. Phospholipse C
delta 1 is a novel 3.22.3 tumour suppressor involved in cytoskeleton organisation with its
epigenetic silencing correlated with high stage gastric cancer. Oncogene 28, 2466-2475.
Hua, J., Chen, D., Fu, H., Zhang, R., Shen, W., Liu, S., et al., 2010. Short hairpin RNA-
mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of
BGC823 gastric cancer cells in vitro and in vivo. Cancer Lett. 292, 41-47.
Hua, K.Q., Yao, L.Q., Cao, Q., Huang, Y., Zhao, Y.Q., Feng, Y.J., 2006. Influence of estrogen
and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation
of phosphorylation signaling. Zhonghua fu chan ke za zhi 41, 756-761. (viewed only as
abstract)
Huang, D., Ding, Y., Luo, W.M., Bender, S., Qian, C.N., Kort, E., et al., 2008. Inhibition of
MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogen-
esis in vivo. Cancer Res. 68, 81-88.
Huang, T.H., Wu, F., Loeb, G.B., Hsu, R., Heidersbach, A., Brincat, A., et al., 2009.
Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J. Biol. Chem.
284, 18515-18524.